コレステロール代謝を調節することによってCD8 ((+) T細胞の抗腫瘍反応を強める
Wei Yang1, Yibing Bai1, Ying Xiong2
1State Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Science Research Center, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Nature
|March 17, 2016
まとめ
CD8 ((+)) T細胞のコレステロールエステル化を阻害することで,その抗がん活性が強化される. このアプローチはACAT1阻害を用いて T細胞の機能を増強することで 癌の免疫療法に希望を示しています
科学分野:
- 免疫学
- 癌 生物学
- 代謝経路
背景:
- CD8 ((+) T細胞は抗腫瘍免疫に不可欠ですが,しばしば腫瘍の微小環境内で抑制されます.
- CD8 ((+) T細胞の細胞毒性を再活性化することは,がん免疫療法における重要な目標である.
研究 の 目的:
- コレステロール代謝を調節することによって,CD8 ((+)) T細胞の抗腫瘍反応を強める新しいメカニズムを調査する.
- T細胞におけるコレステロールのエステル化を標的とした治療の可能性を評価する.
主な方法:
- マウスのCD8 ((+)) T細胞におけるACAT1 (コレステロールエステル化酵素) の遺伝的消去と薬学的抑制.
- T細胞エフェクター機能,増殖,免疫シナプス形成の評価
- ACAT1抑制とアバシミブ治療の抗腫瘍効果を評価するために,メラノーマモデルを用いたインビボ試験.
主要な成果:
- ACAT1の抑制は,血コレステロールを増加させ,T細胞受容体のクラスタリングとシグナル伝達を改善することで,CD8 (((+)) T細胞エフェクター機能と増殖を強めた.
- ACAT1欠乏症のCD8 ((+) T細胞は,マウスにおけるメラノーマの成長と転移の優れた制御を示した.
- ACAT阻害剤のアバシミブは,メラノーマモデルにおいて有意な抗腫瘍効果を示し,抗PD-1抗体との併用療法により有効性が向上した.
結論:
- コレステロール代謝を調節し,特にACAT1を抑制することで,CD8 ((+)) T細胞媒介の抗腫瘍免疫を強化する有効な戦略です.
- ACAT1はがん免疫療法における潜在的な治療標的として特定され,アバシミブは治療薬として有望である.
- ACAT1とPD-1の阻害を併用することで,抗腫瘍反応を強化するシネジスティックなアプローチが提供されます.
関連する概念動画
Cholesterol: Significance and Regulation
1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.9K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cytotoxic T Cells-mediated Immune Response
7.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K


